SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-109304
Filing Date
2024-12-16
Accepted
2024-12-16 16:09:06
Documents
1
Period of Report
2024-12-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 8099
  Complete submission text file 0001213900-24-109304.txt   9639
Mailing Address C/O CITIUS PHARMACEUTICALS, INC. 63 GREAT ROAD MAYNARD MA 01754
Business Address
HOLUBIAK MYRON Z (Reporting) CIK: 0001199080 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41534 | Film No.: 241551871

Mailing Address 420 LEXINGTON AVE, SUITE 2446 NEW YORK NY 10017
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6677
CITIUS ONCOLOGY, INC. (Issuer) CIK: 0001851484 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)